Systems biology approaches to evaluate arsenic toxicity and carcinogenicity: an overview.

[1]  K. Nohara,et al.  Long‐term arsenic exposure induces histone H3 Lys9 dimethylation without altering DNA methylation in the promoter region of p16INK4a and down‐regulates its expression in the liver of mice , 2013, Journal of applied toxicology : JAT.

[2]  M. Banerjee,et al.  Arsenic-induced toxicity and carcinogenicity: a two-wave cross-sectional study in arsenicosis individuals in West Bengal, India , 2013, Journal of Exposure Science and Environmental Epidemiology.

[3]  K. Bhadra,et al.  Poly (lactide-co-glycolide) encapsulated extract of Phytolacca decandra demonstrates better intervention against induced lung adenocarcinoma in mice and on A549 cells. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[4]  K. Rehman,et al.  Arsenic metabolism and thioarsenicals. , 2012, Metallomics : integrated biometal science.

[5]  Fen Wu,et al.  Association between arsenic exposure from drinking water and plasma levels of cardiovascular markers. , 2012, American journal of epidemiology.

[6]  Z. Gregus,et al.  Glutathione synthetase promotes the reduction of arsenate via arsenolysis of glutathione. , 2012, Biochimie.

[7]  C. Marsit,et al.  A case-control study of polymorphisms in xenobiotic and arsenic metabolism genes and arsenic-related bladder cancer in New Hampshire. , 2012, Toxicology letters.

[8]  A. Baccarelli,et al.  Prenatal Arsenic Exposure and DNA Methylation in Maternal and Umbilical Cord Blood Leukocytes , 2012, Environmental health perspectives.

[9]  C. Marsit,et al.  SLC39A2 and FSIP1 polymorphisms as potential modifiers of arsenic-related bladder cancer , 2012, Human Genetics.

[10]  J. Baron,et al.  Genome-Wide Association Study Identifies Chromosome 10q24.32 Variants Associated with Arsenic Metabolism and Toxicity Phenotypes in Bangladesh , 2012, PLoS genetics.

[11]  C. Escudero-Lourdes,et al.  Association of glutathione S-transferase Ω 1-1 polymorphisms (A140D and E208K) with the expression of interleukin-8 (IL-8), transforming growth factor beta (TGF-β), and apoptotic protease-activating factor 1 (Apaf-1) in humans chronically exposed to arsenic in drinking water , 2012, Archives of Toxicology.

[12]  S. O'Bryant,et al.  Low-level arsenic exposure, AS3MT gene polymorphism and cardiovascular diseases in rural Texas counties. , 2012, Environmental research.

[13]  Y. Hsueh,et al.  The polymorphisms of P53 codon 72 and MDM2 SNP309 and renal cell carcinoma risk in a low arsenic exposure area. , 2011, Toxicology and applied pharmacology.

[14]  Y. Hsueh,et al.  Association of heme oxygenase-1 GT-repeat polymorphism with blood pressure phenotypes and its relevance to future cardiovascular mortality risk: an observation based on arsenic-exposed individuals. , 2011, Atherosclerosis.

[15]  B. Palm,et al.  Persistent exposure to arsenic via drinking water in rural Bangladesh despite major mitigation efforts. , 2011, American journal of public health.

[16]  M. Banerjee,et al.  Arsenic-induced Cancers : A Review with Special Reference to Gene, Environment and Their Interaction , 2011 .

[17]  Y. Hsueh,et al.  Genetic polymorphisms in glutathione S-transferase (GST) superfamily and risk of arsenic-induced urothelial carcinoma in residents of southwestern Taiwan , 2011, Journal of Biomedical Science.

[18]  P. Gómez-Rubio,et al.  Association between body mass index and arsenic methylation efficiency in adult women from southwest U.S. and northwest Mexico. , 2011, Toxicology and applied pharmacology.

[19]  S. Nagai,et al.  Nuclear organization in genome stability: SUMO connections , 2011, Cell Research.

[20]  S. Xi,et al.  Metabolic profile and assessment of occupational arsenic exposure in copper- and steel-smelting workers in China , 2011, International archives of occupational and environmental health.

[21]  R. Fry,et al.  Epigenetic Changes in Individuals with Arsenicosis , 2011, Chemical research in toxicology.

[22]  M. Vahter,et al.  Arsenic Exposure and Risk of Spontaneous Abortion, Stillbirth, and Infant Mortality , 2010, Epidemiology.

[23]  B. D. Pimparkar,et al.  Arsenicosis: review of recent advances. , 2010, The Journal of the Association of Physicians of India.

[24]  D. Thomas.  Arsenolysis and thiol-dependent arsenate reduction. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[25]  S. Lam,et al.  Arsenic-related DNA copy-number alterations in lung squamous cell carcinomas , 2010, British Journal of Cancer.

[26]  A. Navas-Acien,et al.  Arsenic in public water supplies and cardiovascular mortality in Spain. , 2010, Environmental Research.

[27]  A. J. Gandolfi,et al.  Monomethylarsonous acid produces irreversible events resulting in malignant transformation of a human bladder cell line following 12 weeks of low-level exposure. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[28]  Y. Hsueh,et al.  Polymorphisms in one-carbon metabolism pathway genes, urinary arsenic profile, and urothelial carcinoma , 2010, Cancer Causes & Control.

[29]  Dianjun Sun,et al.  Serum proteomic profiling analysis of chronic arsenic exposure by using SELDI-TOF-MS technology. , 2010, Toxicology letters.

[30]  M. Cebrián,et al.  Arsenic alters monocyte superoxide anion and nitric oxide production in environmentally exposed children. , 2010, Toxicology and applied pharmacology.

[31]  B. Ganguli,et al.  Comparison of drinking water, raw rice and cooking of rice as arsenic exposure routes in three contrasting areas of West Bengal, India , 2010, Environmental geochemistry and health.

[32]  Guifan Sun,et al.  Effects of folate on arsenic toxicity in Chang human hepatocytes: involvement of folate antioxidant properties. , 2010, Toxicology letters.

[33]  P. Tortora,et al.  Polynucleotide phosphorylase and mitochondrial ATP synthase mediate reduction of arsenate to the more toxic arsenite by forming arsenylated analogues of ADP and ATP. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[34]  D. Butcher,et al.  Investigation of the interaction between arsenic species and thiols via electrospray ionization tandem mass spectrometry , 2010 .

[35]  K. Muegge,et al.  DNA methylation in early development , 2010, Molecular reproduction and development.

[36]  Hongzu Ren,et al.  Genome-wide analysis of BEAS-2B cells exposed to trivalent arsenicals and dimethylthioarsinic acid. , 2010, Toxicology.

[37]  J. Mo,et al.  Global Gene Expression Profiling of Hyperkeratotic Skin Lesions from Inner Mongolians Chronically Exposed to Arsenic , 2009, Toxicologic pathology.

[38]  H. Clewell,et al.  Analysis of genomic dose‐response information on arsenic to inform key events in a mode of action for carcinogenicity , 2009, Environmental and molecular mutagenesis.

[39]  T. Hartung,et al.  Arsenic induces telomerase expression and maintains telomere length in human cord blood cells. , 2009, Toxicology.

[40]  L. Charlet,et al.  Environmental science: Rising arsenic risk? , 2009 .

[41]  O. Fardel,et al.  Redox‐sensitive regulation of gene expression in human primary macrophages exposed to inorganic arsenic , 2009, Journal of cellular biochemistry.

[42]  B. Ganguli,et al.  Arsenic exposure induces genomic hypermethylation , 2009, Environmental toxicology.

[43]  S. Arifeen,et al.  Effects of in utero arsenic exposure on child immunity and morbidity in rural Bangladesh. , 2009, Toxicology letters.

[44]  C. Skibola,et al.  Decreased urinary beta-defensin-1 expression as a biomarker of response to arsenic. , 2008, Toxicological Sciences.

[45]  K. Alimoghaddam,et al.  Telomerase activity and telomere length in patients with acute promyelocytic leukemia: indicative of proliferative activity, disease progression, and overall survival. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[46]  V. Slavkovich,et al.  Folate Deficiency, Hyperhomocysteinemia, Low Urinary Creatinine, and Hypomethylation of Leukocyte DNA Are Risk Factors for Arsenic-Induced Skin Lesions , 2008, Environmental health perspectives.

[47]  Pritha Ghosh,et al.  Toxicogenomics of arsenic: classical ideas and recent advances. , 2008, Mutation research.

[48]  Ellen K Silbergeld,et al.  Arsenic exposure and prevalence of type 2 diabetes in US adults. , 2008, JAMA.

[49]  Donna D. Zhang,et al.  Activation of Nrf2 by arsenite and monomethylarsonous acid is independent of Keap1-C151: enhanced Keap1-Cul3 interaction. , 2008, Toxicology and applied pharmacology.

[50]  B. F. Taylor,et al.  Arsenite-induced mitotic death involves stress response and is independent of tubulin polymerization. , 2008, Toxicology and applied pharmacology.

[51]  Bing Li,et al.  Urinary Arsenic Speciation and its Correlation with 8-OHdG in Chinese Residents Exposed to Arsenic Through Coal Burning , 2008, Bulletin of environmental contamination and toxicology.

[52]  Y. Hsueh,et al.  Arsenic Methylation Capability, Heme Oxygenase-1 and NADPH Quinone Oxidoreductase-1 Genetic Polymorphisms and the Stage and Grade of Urothelial Carcinomas , 2008, Urologia Internationalis.

[53]  Keshav K. Singh,et al.  Evaluation of cell types for assessment of cytogenetic damage in arsenic exposed population , 2008, Molecular Cancer.

[54]  Ian J. Brown,et al.  Human metabolic phenotype diversity and its association with diet and blood pressure , 2008, Nature.

[55]  M. Banerjee,et al.  Arsenic-induced mitochondrial instability leading to programmed cell death in the exposed individuals. , 2008, Toxicology.

[56]  H. Rowland,et al.  Arsenic in hair and nails of individuals exposed to arsenic-rich groundwaters in Kandal province, Cambodia. , 2008, The Science of the total environment.

[57]  Y. Matsui,et al.  Epigenetic events in mammalian germ-cell development: reprogramming and beyond , 2008, Nature Reviews Genetics.

[58]  S. Roychoudhury,et al.  Genetic Variants Associated with Arsenic Susceptibility: Study of Purine Nucleoside Phosphorylase, Arsenic (+3) Methyltransferase, and Glutathione S-Transferase Omega Genes , 2008, Environmental health perspectives.

[59]  W. Hung,et al.  Urothelial carcinomas arising in arsenic‐contaminated areas are associated with hypermethylation of the gene promoter of the death‐associated protein kinase , 2007, Histopathology.

[60]  Andrej Bugrim,et al.  Identification of interspecies concordance of mechanisms of arsenic-induced bladder cancer. , 2007, Toxicology in vitro : an international journal published in association with BIBRA.

[61]  Donna D. Zhang,et al.  Nrf2 protects human bladder urothelial cells from arsenite and monomethylarsonous acid toxicity. , 2007, Toxicology and applied pharmacology.

[62]  Sanchita Bhattacharya,et al.  Activation of Inflammation/NF-κB Signaling in Infants Born to Arsenic-Exposed Mothers , 2007, PLoS genetics.

[63]  Keshav K. Singh,et al.  Genetic determinants of mitochondrial response to arsenic in yeast Saccharomyces cerevisiae. , 2007, Cancer research.

[64]  T. Shea,et al.  Potentiation of arsenic neurotoxicity by folate deprivation: Protective role of S-adenosyl methionine , 2007, Nutritional neuroscience.

[65]  V. Slavkovich,et al.  Genomic methylation of peripheral blood leukocyte DNA: influences of arsenic and folate in Bangladeshi adults. , 2007, The American journal of clinical nutrition.

[66]  Xihong Lin,et al.  Quantitative quality-assessment techniques to compare fractionation and depletion methods in SELDI-TOF mass spectrometry experiments , 2007, Bioinform..

[67]  A. Basu,et al.  Increased chromosome aberration frequencies in the Bowen's patients compared to non-cancerous skin lesions individuals exposed to arsenic. , 2007, Mutation research.

[68]  Jie Jin,et al.  Telomere attrition, and chromosome instability via downregulation of TRF2 contributes to arsenic trioxide-induced apoptosis of human T-cell leukemia cell line molt-4 cells , 2007, Cancer biology & therapy.

[69]  D. Christiani,et al.  Susceptibility to arsenic-induced skin lesions from polymorphisms in base excision repair genes. , 2007, Carcinogenesis.

[70]  I. Bertini,et al.  Metabolomics: available results, current research projects in breast cancer, and future applications. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[71]  M. Vahter,et al.  Association of arsenic exposure during pregnancy with fetal loss and infant death: a cohort study in Bangladesh. , 2007, American journal of epidemiology.

[72]  K. Chaudhuri,et al.  Comparison of health effects between individuals with and without skin lesions in the population exposed to arsenic through drinking water in West Bengal, India , 2007, Journal of Exposure Science and Environmental Epidemiology.

[73]  R. Jirtle,et al.  Environmental epigenomics and disease susceptibility , 2007, Nature Reviews Genetics.

[74]  Thomas J. Smith,et al.  A case-control study of GST polymorphisms and arsenic related skin lesions , 2007, Environmental health : a global access science source.

[75]  L. Cameron,et al.  Arsenic in drinking water and cerebrovascular disease, diabetes mellitus, and kidney disease in Michigan: a standardized mortality ratio analysis , 2007, Environmental health : a global access science source.

[76]  A. Puga,et al.  Long term low-dose arsenic exposure induces loss of DNA methylation. , 2007, Biochemical and biophysical research communications.

[77]  S. Waters,et al.  Arsenic (+3 Oxidation State) Methyltransferase and the Methylation of Arsenicals , 2007, Experimental biology and medicine.

[78]  S. Legrand-Poels,et al.  NF-κB activation by reactive oxygen species: Fifteen years later , 2006 .

[79]  F. Parvez,et al.  Folate and arsenic metabolism: a double-blind, placebo-controlled folic acid-supplementation trial in Bangladesh. , 2006, The American journal of clinical nutrition.

[80]  S. Hirano,et al.  Cytotoxic effects of S-(dimethylarsino)-glutathione: a putative intermediate metabolite of inorganic arsenicals. , 2006, Toxicology.

[81]  B. F. Taylor,et al.  p53 Suppression of Arsenite-Induced Mitotic Catastrophe Is Mediated by p21CIP1/WAF1 , 2006, Journal of Pharmacology and Experimental Therapeutics.

[82]  Pritha Ghosh,et al.  Cytogenetic damage and genetic variants in the individuals susceptible to arsenic‐induced cancer through drinking water , 2006, International journal of cancer.

[83]  S. Khalil,et al.  Dynamic regulation and involvement of the heat shock transcriptional response in arsenic carcinogenesis , 2006, Journal of cellular physiology.

[84]  W. Loenen.  S-adenosylmethionine: jack of all trades and master of everything? , 2006, Biochemical Society transactions.

[85]  Steve Selvin,et al.  Increased Mortality from Lung Cancer and Bronchiectasis in Young Adults after Exposure to Arsenic in Utero and in Early Childhood , 2006, Environmental health perspectives.

[86]  Sarmishtha Chanda,et al.  DNA hypermethylation of promoter of gene p53 and p16 in arsenic-exposed people with and without malignancy. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[87]  K. Hemminki,et al.  Single nucleotide polymorphisms in DNA repair genes and basal cell carcinoma of skin. , 2005, Carcinogenesis.

[88]  C. Klein,et al.  Arsenic, mode of action at biologically plausible low doses: what are the implications for low dose cancer risk? , 2005, Toxicology and applied pharmacology.

[89]  Y. Hsueh,et al.  Arsenic exposure, urinary arsenic speciation, and peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan. , 2005, Toxicology and applied pharmacology.

[90]  E. Cao,et al.  Up-regulation of telomere-binding TRF1, TRF2 related to reactive oxygen species induced by As(2)O(3) in MGC-803 cells. , 2005, European journal of pharmacology.

[91]  Xiuwei Tang,et al.  Mitochondrial damage mediates genotoxicity of arsenic in mammalian cells. , 2005, Cancer research.

[92]  S. Hirano,et al.  A new metabolic pathway of arsenite: arsenic–glutathione complexes are substrates for human arsenic methyltransferase Cyt19 , 2005, Archives of Toxicology.

[93]  Michael D. Waters,et al.  Toxicogenomics and systems toxicology: aims and prospects , 2004, Nature Reviews Genetics.

[94]  Jie Liu,et al.  Chronic inorganic arsenic exposure induces hepatic global and individual gene hypomethylation: implications for arsenic hepatocarcinogenesis. , 2004, Carcinogenesis.

[95]  Takahiko Yoshida,et al.  Chronic health effects in people exposed to arsenic via the drinking water: dose-response relationships in review. , 2004, Toxicology and applied pharmacology.

[96]  L. Yih,et al.  Arsenite induces prominent mitotic arrest via inhibition of G2 checkpoint activation in CGL-2 cells. , 2004, Carcinogenesis.

[97]  Jie Jin,et al.  [Effect of arsenic trioxide on telomerase and telomerase reverse transcriptase in KM3 cell line]. , 2004, Zhongguo shi yan xue ye xue za zhi.

[98]  T. Rossman.  Mechanism of arsenic carcinogenesis: an integrated approach. , 2003, Mutation research.

[99]  F. Caradonna,et al.  Arsenic-induced DNA hypomethylation affects chromosomal instability in mammalian cells. , 2003, Carcinogenesis.

[100]  M. Schmitt,et al.  Effects of arsenic on telomerase and telomeres in relation to cell proliferation and apoptosis in human keratinocytes and leukemia cells in vitro. , 2003, Carcinogenesis.

[101]  M. Blasco,et al.  Oxidative Stress Contributes to Arsenic-induced Telomere Attrition, Chromosome Instability, and Apoptosis* , 2003, Journal of Biological Chemistry.

[102]  H. Chiou,et al.  Gene expression of inflammatory molecules in circulating lymphocytes from arsenic-exposed human subjects. , 2003, Environmental health perspectives.

[103]  Thomas J. Smith,et al.  Arsenic methylation and bladder cancer risk in Taiwan , 2003, Cancer Causes & Control.

[104]  M. Karagas,et al.  FAST TRACK DECREASED DNA REPAIR GENE EXPRESSION AMONG INDIVIDUALS EXPOSED TO ARSENIC IN UNITED STATES DRINKING WATER , 2003 .

[105]  F. Marshall,et al.  Cancer-Specific Loss of β-Defensin 1 in Renal and Prostatic Carcinomas , 2003, Laboratory Investigation.

[106]  Thomas J. Smith,et al.  Arsenic Methylation and Skin Cancer Risk in Southwestern Taiwan , 2003, Journal of occupational and environmental medicine.

[107]  F. Marshall,et al.  Beta Defensin-1, Parvalbumin, and Vimentin: A Panel of Diagnostic Immunohistochemical Markers for Renal Tumors Derived From Gene Expression Profiling Studies Using cDNA Microarrays , 2003, The American journal of surgical pathology.

[108]  A. Meharg,et al.  Arsenic contamination of Bangladesh paddy field soils: implications for rice contribution to arsenic consumption. , 2003, Environmental science & technology.

[109]  P. Laird,et al.  Hypomethylation and hypermethylation of DNA in Wilms tumors , 2002, Oncogene.

[110]  R. Perez-soler,et al.  Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines. , 2002, Molecular pharmacology.

[111]  J. Pounds,et al.  Arsenite disrupts mitosis and induces apoptosis in SV40-transformed human skin fibroblasts. , 2002, Toxicology and applied pharmacology.

[112]  Z. Darżynkiewicz,et al.  Arsenic Trioxide Arrests Cells Early in Mitosis Leading to Apoptosis , 2002, Cell cycle.

[113]  F. Caradonna,et al.  Early induction of genetic instability and apoptosis by arsenic in cultured Chinese hamster cells. , 2002, Mutagenesis.

[114]  M. Manno,et al.  Stress proteins induced by arsenic. , 2001, Toxicology and applied pharmacology.

[115]  K. Jan,et al.  Arsenite induces oxidative DNA adducts and DNA-protein cross-links in mammalian cells. , 2001, Free radical biology & medicine.

[116]  Kazuo T. Suzuki,et al.  Identification of dimethylarsinous and monomethylarsonous acids in human urine of the arsenic-affected areas in West Bengal, India. , 2001, Chemical research in toxicology.

[117]  C. J. Chen,et al.  Arsenic methylation capacity and skin cancer. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[118]  G. Kroemer,et al.  Mitochondria--the Death Signal Integrators , 2000, Science.

[119]  D. Morgan,et al.  Occurrence of monomethylarsonous acid in urine of humans exposed to inorganic arsenic. , 2000, Chemical research in toxicology.

[120]  K. Bhalla,et al.  Arsenic induces apoptosis of multidrug-resistant human myeloid leukemia cells that express Bcr-Abl or overexpress MDR, MRP, Bcl-2, or Bcl-x(L). , 2000, Blood.

[121]  E. Corsini,et al.  Sodium arsenate induces overproduction of interleukin-1alpha in murine keratinocytes: role of mitochondria. , 1999, The Journal of investigative dermatology.

[122]  D. Menzel,et al.  Arsenic disrupts cellular levels of p53 and mdm2: a potential mechanism of carcinogenesis. , 1999, Biochemical and biophysical research communications.

[123]  D B Menzel,et al.  A market basket survey of inorganic arsenic in food. , 1999, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[124]  M. Ihnat,et al.  Differential effects of arsenic(III) and chromium(VI) on nuclear transcription factor binding , 1999, Molecular carcinogenesis.

[125]  G. Kroemer,et al.  Arsenite induces apoptosis via a direct effect on the mitochondrial permeability transition pore. , 1999, Experimental cell research.

[126]  G. Kroemer,et al.  Arsenic trioxide, a novel mitochondriotoxic anticancer agent? , 1999, Journal of the National Cancer Institute.

[127]  Yong Ming Li,et al.  Arsenic targets tubulins to induce apoptosis in myeloid leukemia cells. , 1999, Cancer research.

[128]  R. Ohno,et al.  The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms , 1998, Leukemia.

[129]  J C Reed,et al.  Mitochondria and apoptosis. , 1998, Science.

[130]  Y. Hsueh,et al.  Urinary levels of inorganic and organic arsenic metabolites among residents in an arseniasis-hyperendemic area in Taiwan. , 1998, Journal of toxicology and environmental health. Part A.

[131]  T. Lee,et al.  Arsenite inhibits mitotic division and perturbs spindle dynamics in HeLa S3 cells. , 1998, Carcinogenesis.

[132]  J. Pekkanen,et al.  Urinary Excretion of Arsenic Species After Exposure to Arsenic Present in Drinking Water , 1998, Archives of environmental contamination and toxicology.

[133]  B. Diwan,et al.  Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[134]  G. Endo,et al.  Metabolites of Arsenic Induced Tetraploids and Mitotic Arrest in Cultured Cells , 1997, Archives of environmental contamination and toxicology.

[135]  Wilfred W. Li,et al.  The tumor promoter arsenite stimulates AP‐1 activity by inhibiting a JNK phosphatase. , 1996, The EMBO journal.

[136]  A. Smith,et al.  Arsenic methylation patterns before and after changing from high to lower concentrations of arsenic in drinking water. , 1996, Environmental health perspectives.

[137]  T. Yoshida,et al.  Arsenic induces overexpression of growth factors in human keratinocytes. , 1996, Toxicology and applied pharmacology.

[138]  A. Natarajan,et al.  Chromosomal aberrations in peripheral blood lymphocytes from native Andean women and children from northwestern Argentina exposed to arsenic in drinking water. , 1996, Mutation research.

[139]  A. Smith,et al.  Methylation study of a population environmentally exposed to arsenic in drinking water. , 1996, Environmental health perspectives.

[140]  M. Gonsebatt,et al.  Aneugenic effect of sodium arsenite on human lymphocytes in vitro: an individual susceptibility effect detected. , 1995, Mutation research.

[141]  S. Fukushima,et al.  Cancer induction by an organic arsenic compound, dimethylarsinic acid (cacodylic acid), in F344/DuCrj rats after pretreatment with five carcinogens. , 1995, Cancer research.

[142]  S. Okada,et al.  Gene damage induced in human alveolar type II (L-132) cells by exposure to dimethylarsinic acid. , 1993, Biochemical and biophysical research communications.

[143]  L Capobianco,et al.  Kinetics of the reconstituted dicarboxylate carrier from rat liver mitochondria. , 1989, Biochimica et biophysica acta.

[144]  C. Pickart,et al.  Arsenite inhibits two steps in the ubiquitin-dependent proteolytic pathway. , 1989, The Journal of biological chemistry.

[145]  M. Vahter,et al.  Intracellular distribution and chemical forms of arsenic in rabbits exposed to arsenate , 1989, Biological Trace Element Research.

[146]  K. Reimer,et al.  Arsenic speciation in the environment , 1989 .

[147]  J. Barrett,et al.  Induction of gene amplification by arsenic. , 1988, Science.

[148]  T. Clarkson,et al.  Arsenic uptake and metabolism by liver cells is dependent on arsenic oxidation state. , 1983, Chemico-biological interactions.

[149]  R. Crane,et al.  The effect of arsenate on aerobic phosphorylation. , 1953, The Journal of biological chemistry.

[150]  K. Paunović,et al.  Low levels of arsenic in drinking water and type 2 diabetes in Middle Banat region, Serbia. , 2013, International journal of hygiene and environmental health.

[151]  Seong-Jin Choi,et al.  Effects of Repeated Seafood Consumption on Urinary Excretion of Arsenic Species by Volunteers , 2010, Archives of environmental contamination and toxicology.

[152]  Miao He,et al.  Variations in arsenic methylation capacity and oxidative DNA lesions over a 2-year period in a high arsenic-exposed population , 2009, International archives of occupational and environmental health.

[153]  D. G. Guha Mazumder,et al.  Systemic manifestations in chronic arsenic toxicity in absence of skin lesions in West Bengal. , 2009, The Indian journal of medical research.

[154]  T. Ramírez,et al.  S-adenosyl-L-methionine counteracts mitotic disturbances and cytostatic effects induced by sodium arsenite in HeLa cells. , 2008, Mutation research.

[155]  X. Le,et al.  Arsenic speciation in urine from acute promyelocytic leukemia patients undergoing arsenic trioxide treatment. , 2004, Chemical research in toxicology.

[156]  J. Ward,et al.  Transplacental carcinogenicity of inorganic arsenic in the drinking water: induction of hepatic, ovarian, pulmonary, and adrenal tumors in mice. , 2003, Toxicology and applied pharmacology.

[157]  M. Waalkes,et al.  Application of cDNA microarray to the study of arsenic-induced liver diseases in the population of Guizhou, China. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.

[158]  Kathleen Shordt,et al.  Arsenic in drinking water. , 2001, Journal of environmental health.

[159]  W. Dewey,et al.  Molecular mechanisms for the induction of chromosomal aberrations in CHO cells heated in S phase , 1993, Environmental and molecular mutagenesis.

[160]  A. Páldy,et al.  Chromosomal aberrations in children exposed to high concentration of arsenic in drinking water , 1992 .

[161]  J. G. Farmer,et al.  Use of human metabolic studies and urinary arsenic speciation in assessing arsenic exposure , 1991, Bulletin of environmental contamination and toxicology.

[162]  H. Wohlrab.  Molecular aspects of inorganic phosphate transport in mitochondria. , 1986, Biochimica et biophysica acta.

[163]  H. Roels,et al.  Comparison of the urinary excretion of arsenic metabolites after a single oral dose of sodium arsenite, monomethylarsonate, or dimethylarsinate in man , 1981, International archives of occupational and environmental health.